Last Updated: June 26, 2026

Qilu Pharm Hainan Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for QILU PHARM HAINAN

QILU PHARM HAINAN has nineteen approved drugs.

Summary for Qilu Pharm Hainan

US Patents:	0
Tradenames:	18
Ingredients:	18
NDAs:	19

Drugs and US Patents for Qilu Pharm Hainan

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Qilu Pharm Hainan	FOSAPREPITANT DIMEGLUMINE	fosaprepitant dimeglumine	POWDER;INTRAVENOUS	213106-001	Sep 8, 2020	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	GEFITINIB	gefitinib	TABLET;ORAL	211591-001	Feb 13, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	BORTEZOMIB	bortezomib	INJECTABLE;INTRAVENOUS, SUBCUTANEOUS	210824-001	May 2, 2022	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	219999-003	Feb 4, 2026	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	BUMETANIDE	bumetanide	INJECTABLE;INJECTION	219116-001	Sep 19, 2024	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Qilu Pharm Hainan	DOXORUBICIN HYDROCHLORIDE	doxorubicin hydrochloride	INJECTABLE, LIPOSOMAL;INJECTION	219881-001	Feb 3, 2026	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.